ATE142265T1 - Rekombinante herpes-viren, besonders zur herstellung von impfstoffen, verfahren zur herstellung davon, während des prozesses hergestellte plasmide und durchgesetzte impfstoffe - Google Patents
Rekombinante herpes-viren, besonders zur herstellung von impfstoffen, verfahren zur herstellung davon, während des prozesses hergestellte plasmide und durchgesetzte impfstoffeInfo
- Publication number
- ATE142265T1 ATE142265T1 AT91400634T AT91400634T ATE142265T1 AT E142265 T1 ATE142265 T1 AT E142265T1 AT 91400634 T AT91400634 T AT 91400634T AT 91400634 T AT91400634 T AT 91400634T AT E142265 T1 ATE142265 T1 AT E142265T1
- Authority
- AT
- Austria
- Prior art keywords
- virus
- herpesvirus
- pct
- vaccines
- production
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 8
- 238000000034 method Methods 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 title 1
- 239000013612 plasmid Substances 0.000 title 1
- 230000008569 process Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 241001529453 unidentified herpesvirus Species 0.000 abstract 3
- 241000701083 Bovine alphaherpesvirus 1 Species 0.000 abstract 2
- 241000680578 Canid alphaherpesvirus 1 Species 0.000 abstract 2
- 241000701022 Cytomegalovirus Species 0.000 abstract 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 abstract 2
- 241001502481 Meleagrid alphaherpesvirus 1 Species 0.000 abstract 2
- 102000000505 Ribonucleotide Reductases Human genes 0.000 abstract 2
- 108010041388 Ribonucleotide Reductases Proteins 0.000 abstract 2
- 101800002927 Small subunit Proteins 0.000 abstract 2
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 abstract 2
- 241000272525 Anas platyrhynchos Species 0.000 abstract 1
- 241000283073 Equus caballus Species 0.000 abstract 1
- 241000282324 Felis Species 0.000 abstract 1
- 206010051497 Rhinotracheitis Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9003105A FR2659349B1 (fr) | 1990-03-12 | 1990-03-12 | Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE142265T1 true ATE142265T1 (de) | 1996-09-15 |
Family
ID=9394618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91400634T ATE142265T1 (de) | 1990-03-12 | 1991-03-07 | Rekombinante herpes-viren, besonders zur herstellung von impfstoffen, verfahren zur herstellung davon, während des prozesses hergestellte plasmide und durchgesetzte impfstoffe |
Country Status (11)
Country | Link |
---|---|
US (1) | US5266489A (de) |
EP (1) | EP0447303B1 (de) |
JP (1) | JPH05501206A (de) |
AT (1) | ATE142265T1 (de) |
AU (1) | AU641493B2 (de) |
CA (1) | CA2055489A1 (de) |
DE (1) | DE69121746T2 (de) |
ES (1) | ES2094207T3 (de) |
FR (1) | FR2659349B1 (de) |
IE (1) | IE76725B1 (de) |
WO (1) | WO1991013995A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965138A (en) * | 1985-09-06 | 1999-10-12 | Syntro Corporation | Recombinant chimeric virus and uses thereof |
US5961982A (en) * | 1985-09-06 | 1999-10-05 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
US5928648A (en) * | 1985-09-06 | 1999-07-27 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
US5651972A (en) * | 1989-04-21 | 1997-07-29 | University Of Florida Research Foundation, Inc. | Use of recombinant swine poxvirus as a live vaccine vector |
US6025181A (en) * | 1990-07-06 | 2000-02-15 | University Court Of The University Of Glasgow | Equine herpesvirus-4TK mutant |
DE4110962A1 (de) | 1991-04-05 | 1992-10-08 | Bayer Ag | Equine herpesviren (ehv), die fremd-dna enthalten, verfahren zu ihrer herstellung und ihre verwendung in impfstoffen |
US5853733A (en) * | 1993-02-26 | 1998-12-29 | Syntro Corporation | Recombinant herpesvirus of turkeys and uses thereof |
US6183753B1 (en) * | 1994-08-09 | 2001-02-06 | Schering-Plough Veterinary Corp. | Recombinant chimeric virus and uses thereof |
GB9213882D0 (en) * | 1992-06-30 | 1992-08-12 | Univ Court Of The University O | Live modified equine herpesvirus-4 vaccine |
FR2697534A1 (fr) * | 1992-11-02 | 1994-05-06 | Rhone Merieux | Virus herpès de la dinde recombinant pour la réalisation de vaccin de la maladie de Gumboro, son procédé de préparation et vaccin obtenu. |
US5981175A (en) * | 1993-01-07 | 1999-11-09 | Genpharm Internation, Inc. | Methods for producing recombinant mammalian cells harboring a yeast artificial chromosome |
AU683557B2 (en) * | 1994-03-30 | 1997-11-13 | Virogenetics Corporation | Nucleotide and amino acid sequences of canine herpesvirus GB, GC and GD and uses therefor |
FR2719056B1 (fr) * | 1994-04-20 | 1996-09-06 | Rhone Merieux | Herpesvirus transformés pour exprimer gD in vitro. |
AU4197196A (en) * | 1994-10-26 | 1996-05-23 | Syntro Corporation | Recombinant feline herpes virus |
FR2728795B1 (fr) * | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
US5728557A (en) * | 1995-06-01 | 1998-03-17 | Merck & Co., Inc. | Method of making herpes simplex type 1 mutants and mutants so produced |
FR2741806B1 (fr) * | 1995-11-30 | 1998-02-20 | Rhone Merieux | Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline |
US5753235A (en) * | 1996-02-15 | 1998-05-19 | Heska Corporation | Recombinant canine herpesviruses |
FR2750865B1 (fr) * | 1996-06-27 | 1998-12-04 | Rhone Merieux | Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2 |
FR2751226B1 (fr) * | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
US7439346B2 (en) | 2001-10-12 | 2008-10-21 | Perkinelmer Las Inc. | Nucleic acids arrays and methods of use therefor |
AU2002367886B8 (en) | 2001-10-12 | 2008-08-14 | Perkinelmer Las, Inc. | Compilations of nucleic acids and arrays and methods of using them |
JP2007515947A (ja) * | 2003-10-30 | 2007-06-21 | タフツ−ニュー イングランド メディカル センター | 羊水中の無細胞胎児dnaを使用する出生前診断 |
AU2005249450A1 (en) * | 2004-05-27 | 2005-12-15 | Centocor, Inc. | Cynomolgus prostate specific antigen |
AU2005329405A1 (en) * | 2004-06-15 | 2006-09-28 | Centocor, Inc. | Method for screening agents against human prostate disease |
EP2415783B1 (de) | 2006-10-16 | 2016-12-14 | Genelux Corporation | Modifizierte Impfstoffvirusstämme zur Verwendung in einem Diagnose- und Therapieverfahren |
WO2009137369A1 (en) * | 2008-05-03 | 2009-11-12 | Tufts Medical Center, Inc. | Neonatal salivary genomics |
TR201818883T4 (tr) | 2011-10-21 | 2019-01-21 | Intervet Int Bv | Enfeksiyöz laringotrakeit virüsü ve Newcastle hastalığı virüsü antijenlerini kodlayan rekombinant patojenik olmayan marek hastalığı virüsü yapıları. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU619181B2 (en) * | 1987-03-19 | 1992-01-23 | Synergen, Inc. | Viral vector system for the introduction of foreign dna expression products into gallinaceous birds |
US4992051A (en) | 1987-11-03 | 1991-02-12 | Novagene, Inc. | Infectious bovine rhinotracheitis virus mutants, methods for the production of same and methods for the use of same |
JP3292371B2 (ja) * | 1988-09-13 | 2002-06-17 | メリアル | ウイルスのヌクレオチド配列 |
EP0431668B1 (de) * | 1989-12-04 | 1995-02-15 | Akzo Nobel N.V. | Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor |
-
1990
- 1990-03-12 FR FR9003105A patent/FR2659349B1/fr not_active Expired - Fee Related
-
1991
- 1991-03-07 JP JP3506321A patent/JPH05501206A/ja active Pending
- 1991-03-07 ES ES91400634T patent/ES2094207T3/es not_active Expired - Lifetime
- 1991-03-07 DE DE69121746T patent/DE69121746T2/de not_active Expired - Fee Related
- 1991-03-07 CA CA002055489A patent/CA2055489A1/en not_active Abandoned
- 1991-03-07 WO PCT/FR1991/000184 patent/WO1991013995A1/fr active Application Filing
- 1991-03-07 AT AT91400634T patent/ATE142265T1/de not_active IP Right Cessation
- 1991-03-07 US US07/778,890 patent/US5266489A/en not_active Expired - Fee Related
- 1991-03-07 EP EP91400634A patent/EP0447303B1/de not_active Expired - Lifetime
- 1991-03-07 AU AU75420/91A patent/AU641493B2/en not_active Ceased
- 1991-03-11 IE IE79691A patent/IE76725B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU7542091A (en) | 1991-10-10 |
WO1991013995A1 (fr) | 1991-09-19 |
JPH05501206A (ja) | 1993-03-11 |
ES2094207T3 (es) | 1997-01-16 |
IE910796A1 (en) | 1991-09-25 |
DE69121746D1 (de) | 1996-10-10 |
IE76725B1 (en) | 1997-11-05 |
EP0447303B1 (de) | 1996-09-04 |
US5266489A (en) | 1993-11-30 |
FR2659349B1 (fr) | 1993-12-24 |
AU641493B2 (en) | 1993-09-23 |
CA2055489A1 (en) | 1991-09-13 |
DE69121746T2 (de) | 1997-03-20 |
FR2659349A1 (fr) | 1991-09-13 |
EP0447303A1 (de) | 1991-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE142265T1 (de) | Rekombinante herpes-viren, besonders zur herstellung von impfstoffen, verfahren zur herstellung davon, während des prozesses hergestellte plasmide und durchgesetzte impfstoffe | |
ATE498006T1 (de) | Rekombinantes herpesvirus aus truthähnen und seine verwendungen | |
AU585126B2 (en) | Recombinant herpes simplex viruses, vaccines and methods | |
PL333070A1 (en) | Infectious clones of rna viruses and vaccines based on them | |
EP0544746B1 (de) | Verfahren zur modifizierung von zell-, gewebe- oder wirts-tropismus eines mikroorganismus, so erhaltene rekombinante mikroorganismen sowie deren verwendung in medizin und tiermedizin | |
DE3888290D1 (de) | Mutanten des infektiösen bovinen Rhinotracheitisvirus, Vakzine die sie enthalten, Verfahren zu ihrer Herstellung und ihrer Verwendung. | |
AU4334193A (en) | Infectious bovine rhinotracheitis virus mutants and vaccines | |
ATE244308T1 (de) | Rekombitante, equine herpesviren | |
ZA896986B (en) | Viral vaccines | |
JP2002519068A5 (de) | ||
NZ512125A (en) | An infectious bovine herpesvirus type 1 (BHV-1) having a deleted portion of the native glycoprotein E (gE) coding region and a functional beta-galactosidase gene inserted | |
US5580564A (en) | Method for modifying the cell, tissue or host tropism of microorganisms; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine | |
Vernon et al. | Herpesvirus vaccine development: studies of virus morphological components | |
CA2621088A1 (en) | Genetically engineered fowlpox-based vaccine strain | |
CA2141422A1 (en) | Recombinant equine herpesviruses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EEFA | Change of the company name | ||
REN | Ceased due to non-payment of the annual fee |